Investment Thesis
Pediatrix Medical Group faces severe operational and financial headwinds: negative operating cash flow of -$129.8M indicates the company is burning cash despite reported profitability, while revenue declined 4.9% YoY with net income flat. Returns on equity (3.4%) and assets (1.4%) are critically low, signaling structural business challenges in a competitive healthcare staffing market.
Strengths
- Moderate leverage with 0.45x debt-to-equity ratio provides some balance sheet flexibility
- Adequate cash reserves of $205.8M provide near-term liquidity buffer
- Still generating positive net income of $29.6M despite operational challenges
Risks
- Negative operating cash flow of -$129.8M is unsustainable and indicates core business deterioration
- Revenue contraction of 4.9% YoY signals declining market demand or competitive pressures
- Weak interest coverage ratio of 2.0x leaves limited margin for error if earnings decline further
- Critically low ROE (3.4%) and ROA (1.4%) suggest poor capital efficiency and asset utilization
- Rising shares outstanding risk if EPS gains (263% YoY) are from buybacks masking weak fundamentals
Key Metrics to Watch
- Operating cash flow trend and path to positive FCF generation
- Revenue stabilization and organic growth trajectory
- Return on equity improvement and working capital efficiency
- Debt service coverage ratio and interest coverage capacity
- Quarterly cash burn rate and cash runway sustainability
Financial Metrics
Revenue
476.2M
Net Income
29.6M
EPS (Diluted)
$0.36
Free Cash Flow
-129.8M
Total Assets
2.1B
Cash
205.8M
Profitability Ratios
Gross Margin
N/A
Operating Margin
8.7%
Net Margin
6.2%
ROE
3.4%
ROA
1.4%
FCF Margin
-27.3%
Balance Sheet & Liquidity
Current Ratio
1.33x
Quick Ratio
1.33x
Debt/Equity
0.45x
Debt/Assets
57.6%
Interest Coverage
1.99x
Long-term Debt
398.3M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-07T09:46:48.876649 |
Data as of: 2026-03-31 |
Powered by Claude AI